Status:
UNKNOWN
Development of a Breath Analyzer for Asthma Screening
Lead Sponsor:
Ekips Technologies
Collaborating Sponsors:
American Lung Association
Conditions:
Asthma
Eligibility:
All Genders
4-65 years
Brief Summary
Annually, asthma is responsible for 1 million emergency room visits, 400,000 hospitalizations, and 5000 deaths according to the NHLBI. In addition, 10 million missed school-days per year and 100 milli...
Detailed Description
The study plan is divided into two sections: in-clinic studies and large-scale outreach screening. (A). Clinical Studies The clinical study is intended to obtain data characterizing eNO concentration...
Eligibility Criteria
Inclusion
- Healthy subjects (n=120)
- Asthma (Total n=450) \[diagnosed according to NHLBI/ NAEPP Guidelines (1998)\]
- Non-treated or B2-agonist treated asthmatics (n=150),
- Glucocorticoid treated asthmatics, (n=150),
- Leukotriene Antagonist treated asthmatics, (n=75),
- Glucocorticoid and Leukotriene Antagonists treated asthmatics, (n= 75).
- Acute respiratory illnesses (n=65
- Sinusitis (Acute and Chronic),
- Influenza,
- Common cold,
- Pneumonia,
- Related symptoms, but no diagnosis.
- Allergies (n=65)
- Atopic dermatitis,
- Allergic rhinitis,
- Seasonal allergies.
Exclusion
- Younger than 4
- Older than 65
- Pregnant
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
End Date :
February 1 2007
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00386737
Start Date
September 1 2004
End Date
February 1 2007
Last Update
October 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ekips Technologies, Inc.
Norman, Oklahoma, United States, 73069